I think your statements are consistent but it does seem Tysabri has grown on you a bit with the time since re-launch and lack of safety signals to date. Is that a correct statement? Does the Rituxan safety situation concern you at all - if memory serves it has its own cancer/pseudo-PML issues?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.